FDA Grants Accelerated Approval for First Treatment for Barth Syndrome

THURSDAY, Sept. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the fir